JAK2/STAT3 Axis Intermediates Microglia/Macrophage Polarization During Cerebral Ischemia/Reperfusion Injury

Yi Zhong1, Lijuan Gu2, Yingze Ye1

  • 1Department of Neurosurgery, Renmin Hospital of Wuhan University, China.

Neuroscience
|May 22, 2022
PubMed
Abstract

Insights

The JAK2/STAT3 pathway promotes M2 microglia/macrophage polarization, reducing brain damage in ischemic stroke. Targeting this pathway offers a promising therapeutic strategy for stroke recovery.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Microglia/macrophage subtypes differentially regulate inflammation in ischemic stroke.
  • The JAK2/STAT3 signaling pathway is implicated in stroke-related inflammation.
  • The precise role of JAK2/STAT3 in microglia/macrophage phenotype modulation remains unclear.

Purpose of the Study:

  • To investigate the role of the JAK2/STAT3 signaling pathway in microglia/macrophage polarization during ischemic stroke.
  • To determine the therapeutic potential of targeting JAK2/STAT3 for ischemic stroke.

Main Methods:

  • Established a transient middle cerebral artery occlusion (tMCAO) model in mice with STAT3 knockout in microglia/macrophages.
  • Assessed neurological deficits, infarct volume, and protein/gene expression of inflammatory and polarization markers.
  • Utilized an oxygen-glucose deprivation/reoxygenation (OGD/R) model in BV2 cells to confirm findings.

Main Results:

  • STAT3 knockout exacerbated neurological deficits and infarct volume post-MCAO.
  • STAT3 deletion led to increased M1 (pro-inflammatory) markers (iNOS, CD16/32) and decreased M2 (anti-inflammatory) markers (Arg-1, Ym-1, CD206).
  • STAT3 deletion increased pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) and reduced the p-STAT3/STAT3 ratio, while increasing the p-JAK2/JAK2 ratio.

Conclusions:

  • The JAK2/STAT3 signaling pathway promotes M2 microglia/macrophage polarization, which is protective against ischemic brain damage.
  • Targeting JAK2/STAT3 activation represents a potential therapeutic strategy for ischemic stroke.